Market Cap : 249.2 B | Enterprise Value : 310.95 B | PE Ratio : 19.97 | PB Ratio : 17.01 |
---|
NYSE:ABBV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:ABBV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AbbVie has the GF Value Rank of 5.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
For the Drug Manufacturers - General subindustry, AbbVie's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, AbbVie's GF Value Rank distribution charts can be found below:
* The bar in red indicates where AbbVie's GF Value Rank falls into.
Thank you for viewing the detailed overview of AbbVie's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Sorg Elaine K. | officer: Sr. V.P., U.S. Commercial Ops. | 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Strom Carrie C | officer: SVP & Pres Global Allerg Aesth | 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Rapp Edward J | director | 100 NE ADAMS STREET PEORIA IL 61629 |
Liddy Edward M | director | 2775 SANDERS ROAD NORTHBROOK IL 60062-6127 |
Alpern Robert J | director | YALE SCHOOL OF MEDICINE 333 CEDAR STREET, C203 SHM NEW HAVEN CT 06520 |
Richmond Timothy J. | officer: EVP, Chief HR Officer | 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Hudson Thomas J | officer: SVP, R&D and CSO | 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Donoghoe Nicholas | officer: SVP, Enterprise Innovation | 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Stewart Jeffrey Ryan | officer: SVP, US Commercial Operations | 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Durkin Brian L | officer: VP, Controller | 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Roberts Rebecca B | director | 1000 LOUISIANA SUITE 5800 HOUSTON TX 77002 |
Meyer Melody B | director | 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Michael Robert A. | officer: VP, Controller | 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 |
Hart Brett J | director | 233 S. WACKER DRIVE, 11TH FLOOR CHICAGO IL 60606 |
Gosebruch Henry O | officer: Chief Strategy Officer | 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064-6092 |
Other Sources
By tipranks.com 2022-03-14
By tipranks.com 2022-03-20
By Zacks 2022-03-28
By Fool 2022-03-26
By Zacks 2022-03-22
By tipranks.com 2022-03-10
By tipranks.com 2022-03-11
By tipranks.com 2022-03-09
By Zacks 2022-03-14
By tipranks.com 2022-03-17
By Zacks 2022-03-16
By Zacks 2022-03-11
By Seekingalpha 2022-03-14
By Seekingalpha 2022-03-08